Clinical applications of biomarkers in preeclampsia.

about

Advances in prenatal diagnostics.

P2860

Q48938740-20F34963-D5B8-4F31-A931-B063DA7FBFD7

P2860

Clinical applications of biomarkers in preeclampsia.

Item

http://www.wikidata.org/entity/Q38209381

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical applications of biomarkers in preeclampsia.

@en

type

Item

label

Clinical applications of biomarkers in preeclampsia.

@en

prefLabel

Clinical applications of biomarkers in preeclampsia.

@en

P1476

Clinical applications of biomarkers in preeclampsia.

@en

P2093

Andrew H Shennan

http://www.w3.org/2001/XMLSchema#string

Melanie Griffin

http://www.w3.org/2001/XMLSchema#string

P2860

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

PP13, maternal ABO blood groups and the risk assessment of pregnancy complications

Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia.

Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion.

Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis

Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.

Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review.

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity.

Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia.

P304

459-470

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.14.19

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24796610

http://www.w3.org/2001/XMLSchema#string

P921

pre-eclampsia

maternal health

biomarker

Clinical applications of biomarkers in preeclampsia.

about

P2860

P2860

Clinical applications of biomarkers in preeclampsia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921